| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.36 | 3e-24 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-23 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-13 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-13 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-13 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-12 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-08 |